SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Intuitive Surgical, Inc. (ISRG)
ISRG 534.28+0.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: IceHawk7/20/2018 12:08:21 AM
  Read Replies (1) of 438
 
Cantor Fitzgerald Believes Intuitive Surgical (NASDAQ: ISRG) Still Has Room to Grow


July 19, 2018 By Ryan Adsit


In a report released yesterday, Craig Bijou from Cantor Fitzgerald reiterated a Buy rating on Intuitive Surgical (NASDAQ: ISRG), with a price target of $620. The company’s shares closed yesterday at $521.29, close to its 52-week high of $532.30.

Bijou commented:

“: We reiterate our Overweight rating on shares of ISRG and raise our price target to $620 from $510. Quarter after quarter, ISRG continues to justify its premium valuation, again significantly beating on all metrics we track, including the top and bottom line. ISRG delivered 18% procedure growth for 2Q18, one of the strongest quarterly procedure growth figures y/y in the last five years, with broad strength across all procedure categories. ISRG raised full-year 2018 procedure growth guidance to 14.5-16.5% from 12-15%. The installed based grew 12% and utilization was up by mid-single digits.”
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext